BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25957636)

  • 21. Neuropsychological impairment in amyotrophic lateral sclerosis-frontotemporal spectrum disorder.
    Abrahams S
    Nat Rev Neurol; 2023 Nov; 19(11):655-667. PubMed ID: 37828358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deficits in concept formation in amyotrophic lateral sclerosis.
    Libon DJ; McMillan C; Avants B; Boller A; Morgan B; Burkholder L; Chandrasekaran K; Elman L; McCluskey L; Grossman M
    Neuropsychology; 2012 Jul; 26(4):422-9. PubMed ID: 22612577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for cognition and behaviour changes in ALS.
    Abrahams S; Newton J; Niven E; Foley J; Bak TH
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):9-14. PubMed ID: 23781974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis?
    Taylor LJ; Brown RG; Tsermentseli S; Al-Chalabi A; Shaw CE; Ellis CM; Leigh PN; Goldstein LH
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):494-8. PubMed ID: 23033353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidimensional apathy and executive dysfunction in amyotrophic lateral sclerosis.
    Radakovic R; Stephenson L; Newton J; Crockford C; Swingler R; Chandran S; Abrahams S
    Cortex; 2017 Sep; 94():142-151. PubMed ID: 28759804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) in frontotemporal dementia.
    Saxon JA; Thompson JC; Harris JM; Ealing J; Hamdalla H; Chaouch A; Young C; Blackburn D; Majeed T; Gall C; Richardson AMT; Langheinrich T; Jones M; Snowden JS
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Nov; 21(7-8):606-613. PubMed ID: 32811199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Executive dysfunction and survival in patients with amyotrophic lateral sclerosis: Preliminary report from a Serbian centre for motor neuron disease.
    Stojkovic T; Stefanova E; Pekmezovic T; Peric S; Stevic Z
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):543-547. PubMed ID: 27494074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. White matter structural network abnormalities underlie executive dysfunction in amyotrophic lateral sclerosis.
    Dimond D; Ishaque A; Chenji S; Mah D; Chen Z; Seres P; Beaulieu C; Kalra S
    Hum Brain Mapp; 2017 Mar; 38(3):1249-1268. PubMed ID: 27796080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of theory of mind with language and visuospatial abilities in amyotrophic lateral sclerosis: a pilot study.
    Panopoulou N; Christidi F; Kourtesis P; Ferentinos P; Karampetsou P; Tsirtsiridis G; Theodosiou T; Xirou S; Zouvelou V; Evdokimidis I; Rentzos M; Zalonis I
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):462-469. PubMed ID: 34907827
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuropsychological assessment in different King's clinical stages of amyotrophic lateral sclerosis.
    Trojsi F; Santangelo G; Caiazzo G; Siciliano M; Ferrantino T; Piccirillo G; Femiano C; Cristillo V; Monsurrò MR; Esposito F; Tedeschi G
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(3-4):228-35. PubMed ID: 26905940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An observational study of cognitive impairment in amyotrophic lateral sclerosis.
    Rippon GA; Scarmeas N; Gordon PH; Murphy PL; Albert SM; Mitsumoto H; Marder K; Rowland LP; Stern Y
    Arch Neurol; 2006 Mar; 63(3):345-52. PubMed ID: 16533961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can executive cognitive measures differentiate between patients with spinal- and bulbar-onset amyotrophic lateral sclerosis?
    Zalonis I; Christidi F; Paraskevas G; Zabelis T; Evdokimidis I; Kararizou E
    Arch Clin Neuropsychol; 2012 May; 27(3):348-54. PubMed ID: 22403771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cognitive and behavioural profile of amyotrophic lateral sclerosis: application of the consensus criteria.
    Consonni M; Iannaccone S; Cerami C; Frasson P; Lacerenza M; Lunetta C; Corbo M; Cappa SF
    Behav Neurol; 2013; 27(2):143-53. PubMed ID: 23001631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive dysfunction in lower motor neuron disease: executive and memory deficits in progressive muscular atrophy.
    Raaphorst J; de Visser M; van Tol MJ; Linssen WH; van der Kooi AJ; de Haan RJ; van den Berg LH; Schmand B
    J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):170-5. PubMed ID: 20562407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations.
    Oh SI; Park A; Kim HJ; Oh KW; Choi H; Kwon MJ; Ki CS; Kim HT; Kim SH
    PLoS One; 2014; 9(2):e87163. PubMed ID: 24498297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Female gender doubles executive dysfunction risk in ALS: a case-control study in 165 patients.
    Palmieri A; Mento G; Calvo V; Querin G; D'Ascenzo C; Volpato C; Kleinbub JR; Bisiacchi PS; Sorarù G
    J Neurol Neurosurg Psychiatry; 2015 May; 86(5):574-9. PubMed ID: 25063584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inside minds, beneath diseases: social cognition in amyotrophic lateral sclerosis-frontotemporal spectrum disorder.
    Lillo P; Caramelli P; Musa G; Parrao T; Hughes R; Aragon A; Valenzuela D; Cea G; Aranguiz R; Guimarães HC; Rousseff L; Gambogi LB; Mariano LI; Teixeira AL; Slachevsky A; de Souza LC
    J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1279-1282. PubMed ID: 32962983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Communication and pragmatic breakdowns in amyotrophic lateral sclerosis patients.
    Bambini V; Arcara G; Martinelli I; Bernini S; Alvisi E; Moro A; Cappa SF; Ceroni M
    Brain Lang; 2016 Feb; 153-154():1-12. PubMed ID: 26799425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual encoding, consolidation, and retrieval in amyotrophic lateral sclerosis: executive function as a mediator, and predictor of performance.
    Burke T; Lonergan K; Pinto-Grau M; Elamin M; Bede P; Madden C; Hardiman O; Pender N
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):193-201. PubMed ID: 28084080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eye-tracking controlled cognitive function tests in patients with amyotrophic lateral sclerosis: a controlled proof-of-principle study.
    Keller J; Gorges M; Horn HT; Aho-Özhan HE; Pinkhardt EH; Uttner I; Kassubek J; Ludolph AC; Lulé D
    J Neurol; 2015 Aug; 262(8):1918-26. PubMed ID: 26041615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.